Michael Snyder

Michael Snyder

Stanford University

H-index: 203

North America-United States

Professor Information

University

Stanford University

Position

___

Citations(all)

207584

Citations(since 2020)

80807

Cited By

157779

hIndex(all)

203

hIndex(since 2020)

130

i10Index(all)

719

i10Index(since 2020)

567

Email

University Profile Page

Stanford University

Research & Interests List

Genetics

Omics

Proteomics

Medicine

Health

Top articles of Michael Snyder

The importance, challenges, and possible solutions for sharing proteomics data while safeguarding individuals’ privacy

Proteomics data sharing has profound benefits at individual level as well as at community level. While data sharing has increased over the years, mostly due to journal and funding agency requirements, the reluctance of researchers with regards to data sharing is evident as many shares only the bare minimum dataset required to publish an article. In many cases, proper metadata is missing, essentially making the dataset useless. This behavior can be explained by lack of incentives, insufficient awareness, or a lack of clarity surrounding ethical issues. Through adequate training at research institutes, researchers can realize the benefits associated with data sharing and can accelerate the norm of data sharing for the field of proteomics, as has been the standard in genomics for decades. In this article, we have put together various repository options available for proteomics data. We have also added pros and cons of …

Authors

Mahasish Shome,Tim MG MacKenzie,Smitha R Subbareddy,Michael P Snyder

Published Date

2024/2/7

Accelerated Hematopoietic Stem Cell Aging in Space

Stem cell aging is accelerated by macroenvironmental and microenvironmental stressors, including inflammation. Previously, the NASA Twins study revealed inflammatory cytokine upregulation, chromosomal alterations, and telomere changes suggestive of accelerated aging in low-Earth orbit (LEO). To investigate the effects of spaceflight on human hematopoietic stem and progenitor cell (HSPC) aging, the NASA-supported Integrated Space Stem Cell Orbital Research team performed four independent 30- to 45-day NASA missions with matched flight and ground HSPC nanobioreactors in automated CubeLabs. These experiments revealed loss of HSPC dormancy, reduced self-renewal capacity, mitochondrial DNA amplification, APOBEC3-induced C-to-T mutagenesis, reduced ADAR1p150 expression, and alterations in the expression of repetitive elements. These molecular changes are indicative of accelerated HSPC aging and pre-leukemia stem cell generation in space and may be predictable and preventable.

Authors

Jessica Pham,Jane Isquith,Larisa Balaian,Luisa Ladel,Shuvro P Nandi,Karla Mack,Inge van der Werf,Emma Klacking,Antonio Ruiz,David Mays,Paul Gamble,Shelby Giza,Jiya Janowitz,Trevor Nienaber,Tejaswini Mishra,Anna Kulidjian,Jana Stoudemire,Michael P Snyder,Twyman Clements,Alysson R Muotri,Sheldon R Morris,Thomas Whisenant,Ludmil B Alexandrov,Catriona HM Jamieson

Journal

bioRxiv

Published Date

2024

Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease involving selective vulnerability of energy-intensive motor neurons (MNs). It has been unclear whether mitochondrial function is an upstream driver or a downstream modifier of neurotoxicity. We separated upstream genetic determinants of mitochondrial function, including genetic variation within the mitochondrial genome or autosomes; from downstream changeable factors including mitochondrial DNA copy number (mtCN). Across three cohorts including 6,437 ALS patients, we discovered that a set of mitochondrial haplotypes, chosen because they are linked to measurements of mitochondrial function, are a determinant of ALS survival following disease onset, but do not modify ALS risk. One particular haplotype appeared to be neuroprotective and was significantly over-represented in two cohorts of long-surviving ALS patients. Causal …

Authors

Calum Harvey,Marcel Weinreich,James AK Lee,Allan C Shaw,Laura Ferraiuolo,Heather Mortiboys,Sai Zhang,Paul J Hop,Ramona AJ Zwamborn,Kristel van Eijk,Thomas H Julian,Tobias Moll,Alfredo Iacoangeli,Ahmad Al Khleifat,John P Quinn,Abigail L Pfaff,Sulev Kõks,Joanna Poulton,Stephanie L Battle,Dan E Arking,Michael P Snyder,Jan H Veldink,Kevin P Kenna,Pamela J Shaw,Johnathan Cooper-Knock

Journal

Heliyon

Published Date

2024/2/15

Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C (= O) C (NC (= O) C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C (C) CC) CSSCC (C (NC (CO) C (= O) NC (CC (C) C) C (= O) NC (CC= 2C= CC (O)= CC= 2) C (= O) NC (CCC (N)= O) C (= O) NC (CC (C) C) C (= O) NC (CCC (O)= O) C (= O) NC (CC (N)= O) C (= O) NC (CC= 2C= CC (O)= CC= 2) C (= O) NC (CSSCC (NC (= O) C (C (C) C) NC (= O) C (CC (C) C) NC (= O) C (CC= 2C= CC (O)= CC= 2) NC (= O) C (CC (C) C) NC (= O) C (C) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (CC (C) C) NC (= O) C (CC= 2NC= NC= 2) NC (= O) C (CO) NC (= O) CNC2= O) C (= O) NCC (= O) NC (CCC (O)= O) C (= O) NC (CCCNC (N)= N) C (= O) NCC (= O) NC (CC= 3C= CC= CC= 3) C (= O) NC (CC= 3C= CC= CC= 3) C (= O) NC (CC= 3C= CC (O)= CC= 3) C (= O) NC (C (C) O) C (= O) N3C …

Published Date

2024/3/12

Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease

To understand the dynamic interplay between the human microbiome and host during health and disease, we analyzed the microbial composition, temporal dynamics, and associations with host multi-omics, immune, and clinical markers of microbiomes from four body sites in 86 participants over 6 years. We found that microbiome stability and individuality are body-site specific and heavily influenced by the host. The stool and oral microbiome are more stable than the skin and nasal microbiomes, possibly due to their interaction with the host and environment. We identify individual-specific and commonly shared bacterial taxa, with individualized taxa showing greater stability. Interestingly, microbiome dynamics correlate across body sites, suggesting systemic dynamics influenced by host-microbial-environment interactions. Notably, insulin-resistant individuals show altered microbial stability and associations among …

Authors

Xin Zhou,Xiaotao Shen,Jethro S Johnson,Daniel J Spakowicz,Melissa Agnello,Wenyu Zhou,Monica Avina,Alexander Honkala,Faye Chleilat,Shirley Jingyi Chen,Kexin Cha,Shana Leopold,Chenchen Zhu,Lei Chen,Lin Lyu,Daniel Hornburg,Si Wu,Xinyue Zhang,Chao Jiang,Liuyiqi Jiang,Lihua Jiang,Ruiqi Jian,Andrew W Brooks,Meng Wang,Kévin Contrepois,Peng Gao,Sophia Miryam Schüssler-Fiorenza Rose,Thi Dong Binh Tran,Hoan Nguyen,Alessandra Celli,Bo-Young Hong,Eddy J Bautista,Yair Dorsett,Paula B Kavathas,Yanjiao Zhou,Erica Sodergren,George M Weinstock,Michael P Snyder

Journal

Cell Host & Microbe

Published Date

2024/4/10

Abstract PO3-24-02: Molecular characterization and therapeutic approach for VISTA+ triple-negative breast cancers

Introduction: Current FDA-approved immunotherapeutics for triple-negative breast cancer are only available for a subset of patients, highlighting the need to develop improved immune-targeting strategies. VISTA (V-domain Ig suppressor of T cell activation) is a single-pass transmembrane immune checkpoint receptor that is an emerging clinical target for cancer immunotherapy. It is expressed widely on lymphoid and myeloid cells in healthy individuals, is commonly expressed on cells of the tumor microenvironment and can be abnormally upregulated on tumor cells in a wide variety of tumors. Although VISTA confers quiescence to naïve T cells, molecular mechanisms responsible for this effect remain unclear. Also, the effects of VISTA expression on tumor cells remains poorly defined. Methods: Multi-omic profiling was performed in human breast cancer cells lines to determine immune regulatory genes controlled …

Authors

Yan Zhao,Fatima Charles,Andrew Lipchik,Yan Peng,James Ford,Melinda Telli,Song Zhang,Allison Kurian,Michael Snyder,Joshua Gruber

Journal

Cancer Research

Published Date

2024/5/2

Multi-omics microsampling for the profiling of lifestyle-associated changes in health

Current healthcare practices are reactive and use limited physiological and clinical information, often collected months or years apart. Moreover, the discovery and profiling of blood biomarkers in clinical and research settings are constrained by geographical barriers, the cost and inconvenience of in-clinic venepuncture, low sampling frequency and the low depth of molecular measurements. Here we describe a strategy for the frequent capture and analysis of thousands of metabolites, lipids, cytokines and proteins in 10 μl of blood alongside physiological information from wearable sensors. We show the advantages of such frequent and dense multi-omics microsampling in two applications: the assessment of the reactions to a complex mixture of dietary interventions, to discover individualized inflammatory and metabolic responses; and deep individualized profiling, to reveal large-scale molecular fluctuations as …

Authors

Xiaotao Shen,Ryan Kellogg,Daniel J Panyard,Nasim Bararpour,Kevin Erazo Castillo,Brittany Lee-McMullen,Alireza Delfarah,Jessalyn Ubellacker,Sara Ahadi,Yael Rosenberg-Hasson,Ariel Ganz,Kevin Contrepois,Basil Michael,Ian Simms,Chuchu Wang,Daniel Hornburg,Michael P Snyder

Journal

Nature Biomedical Engineering

Published Date

2024/1

A Multiomics, Spatiotemporal, and Single Cell Atlas for Mapping Cell-Type-Specific Dysregulation at the Maternal-Fetal Interface

The placenta, the first organ to functionally mature, undergoes disordered development in many pregnancy complications. Molecular investigations have been hampered by the extreme cellular heterogeneity of the placenta, and this complexity is further exaggerated at the maternal-fetal interface where maternal and fetal cells co-mingle. We generated the paired single nucleus epigenomes and transcriptome for each of ~200,000 cells at the human maternal-fetal interface from early pregnancy to term. These data identified cell-type-specific transcriptional regulatory programs and uncovered key transcription factors driving the lineage differentiation of placental cytotrophoblasts. Integrating spatial single cell proteomics profiling, we localized the observed cell types in situ, and characterized the dynamic stages and distinct features of endothelial cells of maternal spiral arteries remodeled by extravillous cytotrophoblasts. Integrative analyses of the single cell data across gestation enabled fine-mapping of the developmental trajectories of cytotrophoblasts and decidual stromal cells, and defining the signature molecular profiles of known and novel cell (sub)types. To demonstrate clinical value, we integrated the reference single cell data with large-scale population genomes from pregnancy complications and identified the most vulnerable maternal and fetal cell types in preeclampsia, preterm birth and miscarriage. This study presents the most comprehensive placental and decidual single cell resource across gestation to date, reveals new insights into the drivers of normal human placentation, and uncovers the cellular basis of dysfunction associated …

Authors

Cheng Wang,Yan Zhou,Yuejun Wang,Tuhin Kumar Guha,Zhida Luo,Tara I McIntyre,Marisa E Schwab,Brittany R Davidson,Gabriella C Reeder,Ronald J Wong,Sarah England,Juan M Gonzalez,Robert Blelloch,Alexis J Combes,Linda C Giudice,Adrian Erlebacher,Tippi C MacKenzie,David K Stevenson,Gary M Shaw,Michael P Snyder,Susan J Fisher,Viriginia D Winn,Jingjing Li

Journal

bioRxiv

Published Date

2024

academic-engine

Useful Links